Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
6.37
+0.07 (1.11%)
Nov 2, 2026, 3:16 PM EST - Market open
Nutriband Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 1.62 | 2.04 | 2.14 | 2.09 | 2.08 | 1.42 | |
Revenue Growth | -37.25% | -4.81% | 2.60% | 0.27% | 46.23% | 50.70% |
Cost of Revenue | 1.08 | 1.47 | 1.4 | 1.22 | 1.33 | 0.92 |
Gross Profit | 0.54 | 0.57 | 0.74 | 0.86 | 0.75 | 0.5 |
Selling, General & Admin | 6.37 | 6.99 | 4.31 | 3.77 | 3.92 | 4.02 |
Research & Development | 1.21 | 1.89 | 3.12 | 1.96 | 0.98 | 0.41 |
Operating Expenses | 7.58 | 8.88 | 7.43 | 5.73 | 4.9 | 4.43 |
Operating Income | -7.05 | -8.32 | -6.69 | -4.87 | -4.15 | -3.93 |
Interest Expense | -0.03 | -0.02 | -0.02 | -0.08 | -0.01 | -0.12 |
Interest & Investment Income | - | - | - | 0.02 | - | - |
Other Non Operating Income (Expenses) | 0.11 | 0.11 | 0.19 | - | - | - |
EBT Excluding Unusual Items | -6.96 | -8.23 | -6.52 | -4.93 | -4.16 | -4.05 |
Impairment of Goodwill | - | - | -3.6 | - | -0.33 | -2.18 |
Other Unusual Items | - | - | -0.37 | -0.55 | - | 0.05 |
Pretax Income | -6.96 | -8.23 | -10.48 | -5.49 | -4.48 | -6.18 |
Net Income | -6.96 | -8.23 | -10.48 | -5.49 | -4.48 | -6.18 |
Preferred Dividends & Other Adjustments | - | 21.81 | - | - | - | 0.2 |
Net Income to Common | -6.96 | -30.04 | -10.48 | -5.49 | -4.48 | -6.37 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 12 | 11 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 12 | 12 | 11 | 8 | 8 | 8 |
Shares Change | 8.93% | 9.74% | 33.36% | -5.97% | 6.64% | 17.82% |
EPS (Basic) | -0.57 | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
EPS (Diluted) | -0.57 | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Free Cash Flow | -3.63 | -5.14 | -4.72 | -3.58 | -3.07 | -2.89 |
Free Cash Flow Per Share | -0.30 | -0.44 | -0.45 | -0.45 | -0.36 | -0.36 |
Gross Margin | 33.14% | 27.81% | 34.74% | 41.34% | 36.08% | 35.46% |
Operating Margin | -435.58% | -408.41% | -312.67% | -233.63% | -199.45% | -276.33% |
Profit Margin | -430.43% | -1475.16% | -489.95% | -263.05% | -215.59% | -448.10% |
Free Cash Flow Margin | -224.54% | -252.37% | -220.54% | -171.64% | -147.46% | -203.27% |
EBITDA | -6.9 | -8.12 | -6.4 | -4.58 | -3.82 | -3.62 |
EBITDA Margin | - | - | -299.34% | -219.83% | -183.58% | -254.63% |
D&A For EBITDA | 0.15 | 0.19 | 0.29 | 0.29 | 0.33 | 0.31 |
EBIT | -7.05 | -8.32 | -6.69 | -4.87 | -4.15 | -3.93 |
EBIT Margin | - | - | - | -233.63% | -199.45% | -276.33% |